Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 5/2011

01-10-2011 | Clinical Investigation

Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up

Authors: Jean Palussière, Benjamin Marcet, Edouard Descat, Frédéric Deschamps, Pramod Rao, Alain Ravaud, Véronique Brouste, Thierry de Baère

Published in: CardioVascular and Interventional Radiology | Issue 5/2011

Login to get access

Abstract

Purpose

To describe the morphologic evolution of lung tumors treated with radiofrequency ablation (RFA) by way of computed tomography (CT) images and to investigate patterns of incomplete RFA at the site of ablation.

Materials and Methods

One hundred eighty-nine patients with 350 lung tumors treated with RFA underwent CT imaging at 2, 4, 6, and 12 months. CT findings were interpreted separately by two reviewers with consensus. Five different radiologic patterns were predefined: fibrosis, cavitation, nodule, atelectasis, and disappearance. The appearance of the treated area was evaluated at each follow-up CT using the predefined patterns.

Results

At 1 year after treatment, the most common evolutions were fibrosis (50.5%) or nodules (44.8%). Differences were noted depending on the initial size of the tumor, with fibrosis occurring more frequently for tumors <2 cm (58.6% vs. 22.9%, P = 1 × 10−5). Cavitation and atelectasis were less frequent patterns (2.4% and 1.4%, respectively, at 1 year). Tumor location (intraparenchymatous, with pleural contact <50% or >50%) was not significantly correlated with follow-up image pattern. Local tumor progressions were observed with each type of evolution. At 1 year, 12 local recurrences were noted: 2 cavitations, which represented 40% of the cavitations noted at 1 year; 2 fibroses (1.9%); 7 nodules (7.4%); and 1 atelectasis (33.3%).

Conclusion

After RFA of lung tumors, follow-up CT scans show that the shape of the treatment zone can evolve in five different patterns. None of these patterns, however, can confirm the absence of further local tumor progression at subsequent follow-up.
Literature
1.
go back to reference Abbas G, Schuchert MJ, Pennathur A et al (2007) Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 17:261–271PubMedCrossRef Abbas G, Schuchert MJ, Pennathur A et al (2007) Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 17:261–271PubMedCrossRef
2.
go back to reference Dupuy DE, Mayo-Smith WW, Abbott GF et al (2002) Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 22(Spec No.):S259–S269PubMed Dupuy DE, Mayo-Smith WW, Abbott GF et al (2002) Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 22(Spec No.):S259–S269PubMed
3.
go back to reference Rose SC, Thistlethwaite PA, Sewell PE et al (2006) Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17:927–951PubMedCrossRef Rose SC, Thistlethwaite PA, Sewell PE et al (2006) Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17:927–951PubMedCrossRef
4.
go back to reference de Baère T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean followup of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed de Baère T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean followup of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed
5.
go back to reference Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240PubMedCrossRef Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240PubMedCrossRef
6.
go back to reference McGrane S, McSweeney SE, Maher MM (2008) Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging 33:48–53PubMedCrossRef McGrane S, McSweeney SE, Maher MM (2008) Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging 33:48–53PubMedCrossRef
7.
go back to reference Suppiah A, White TJ, Roy-Choudhury SH et al (2007) Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg 24:358–360PubMedCrossRef Suppiah A, White TJ, Roy-Choudhury SH et al (2007) Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg 24:358–360PubMedCrossRef
8.
go back to reference Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities. Part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities. Part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef
9.
go back to reference Zagoria RJ, Traver MA, Werle DM et al (2007) Oncologic efficacy of computed tomography (CT)-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436PubMedCrossRef Zagoria RJ, Traver MA, Werle DM et al (2007) Oncologic efficacy of computed tomography (CT)-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436PubMedCrossRef
10.
go back to reference Park S, Cadeddu JA (2007) Outcomes of radiofrequency ablation for kidney cancer. Cancer Control 14:205–210PubMed Park S, Cadeddu JA (2007) Outcomes of radiofrequency ablation for kidney cancer. Cancer Control 14:205–210PubMed
11.
go back to reference Link TM, de Mayo R, O’Donnell RJ (2007) Radiofrequency ablation: an alternative for definitive treatment of solitary bone metastases. Eur Radiol 17:3012–3013PubMedCrossRef Link TM, de Mayo R, O’Donnell RJ (2007) Radiofrequency ablation: an alternative for definitive treatment of solitary bone metastases. Eur Radiol 17:3012–3013PubMedCrossRef
12.
go back to reference Suh R, Reckamp K, Zeidler M et al (2005) Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 19(11 Suppl 4):12–21 Suh R, Reckamp K, Zeidler M et al (2005) Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 19(11 Suppl 4):12–21
13.
go back to reference Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–275PubMedCrossRef Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–275PubMedCrossRef
14.
go back to reference Yan TD, King J, Sjarif A et al (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13:1529–1537PubMedCrossRef Yan TD, King J, Sjarif A et al (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13:1529–1537PubMedCrossRef
15.
go back to reference Yan TD, King J, Sjarif A et al (2007) Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 14:1718–1726PubMedCrossRef Yan TD, King J, Sjarif A et al (2007) Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 14:1718–1726PubMedCrossRef
16.
go back to reference de Baère T, Palussière J, Auperin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596PubMedCrossRef de Baère T, Palussière J, Auperin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596PubMedCrossRef
17.
go back to reference Therasse P (2002) Evaluation of response: new and standard criteria. Ann Oncol 13(Suppl 4):127–129PubMedCrossRef Therasse P (2002) Evaluation of response: new and standard criteria. Ann Oncol 13(Suppl 4):127–129PubMedCrossRef
18.
go back to reference Shuster JJ (1991) Median follow-up in clinical trials. J Clin Oncol 9:191–192PubMed Shuster JJ (1991) Median follow-up in clinical trials. J Clin Oncol 9:191–192PubMed
19.
go back to reference Ahmed M, Liu Z, Afzal KS et al (2004) Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230:761–767PubMedCrossRef Ahmed M, Liu Z, Afzal KS et al (2004) Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230:761–767PubMedCrossRef
20.
go back to reference Goldberg SN, Gazelle GS, Compton CC et al (1995) Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 2:776–784PubMedCrossRef Goldberg SN, Gazelle GS, Compton CC et al (1995) Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 2:776–784PubMedCrossRef
21.
go back to reference Yamamoto A, Nakamura K, Matsuoka T et al (2005) Radiofrequency ablation in a porcine lung model: correlation between computed tomography (CT) and histopathologic findings. AJR Am J Roentgenol 185:1299–1306PubMedCrossRef Yamamoto A, Nakamura K, Matsuoka T et al (2005) Radiofrequency ablation in a porcine lung model: correlation between computed tomography (CT) and histopathologic findings. AJR Am J Roentgenol 185:1299–1306PubMedCrossRef
22.
go back to reference Suh RD, Wallace AB, Sheehan RE et al (2003) Unresectable pulmonary malignancies: computed tomography (CT)-guided percutaneous radiofrequency ablation: preliminary results. Radiology 229:821–829PubMedCrossRef Suh RD, Wallace AB, Sheehan RE et al (2003) Unresectable pulmonary malignancies: computed tomography (CT)-guided percutaneous radiofrequency ablation: preliminary results. Radiology 229:821–829PubMedCrossRef
23.
go back to reference Steinke K, Glenn D, King J et al (2004) Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11:207–212PubMedCrossRef Steinke K, Glenn D, King J et al (2004) Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11:207–212PubMedCrossRef
24.
go back to reference Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) computed tomography (CT) imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185:466–471PubMed Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) computed tomography (CT) imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185:466–471PubMed
25.
go back to reference Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125–134PubMedCrossRef Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125–134PubMedCrossRef
26.
go back to reference Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 32:478–483PubMedCrossRef Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 32:478–483PubMedCrossRef
27.
go back to reference Brace CL, Diaz TA, Hinshaw JL et al (2010) Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol 21:1280–1286PubMedCrossRef Brace CL, Diaz TA, Hinshaw JL et al (2010) Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol 21:1280–1286PubMedCrossRef
28.
go back to reference Hakimé A, Peddi H, Hines-Peralta AU et al (2007) computed tomography (CT) perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology 243:712–719PubMedCrossRef Hakimé A, Peddi H, Hines-Peralta AU et al (2007) computed tomography (CT) perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology 243:712–719PubMedCrossRef
29.
go back to reference Schaefer JF, Vollmar J, Schick F et al (2004) Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging–perfusion differences in malignant and benign lesions. Radiology 232:544–553PubMedCrossRef Schaefer JF, Vollmar J, Schick F et al (2004) Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging–perfusion differences in malignant and benign lesions. Radiology 232:544–553PubMedCrossRef
30.
go back to reference VanSonnenberg E, Shankar S, Morrison PR et al (2005) Radiofrequency ablation of thoracic lesions. Part 2. Initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184:381–390PubMed VanSonnenberg E, Shankar S, Morrison PR et al (2005) Radiofrequency ablation of thoracic lesions. Part 2. Initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184:381–390PubMed
31.
go back to reference Okuma T, Matsuoka T, Yamamoto A et al (2009) Assessment of early treatment response after computed tomography (CT)-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol 82:989–994PubMedCrossRef Okuma T, Matsuoka T, Yamamoto A et al (2009) Assessment of early treatment response after computed tomography (CT)-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol 82:989–994PubMedCrossRef
32.
go back to reference Okuma T, Matsuoka T, Okamura T et al (2006) 18F-FDG small-animal PET for monitoring the therapeutic effect of computed tomography (CT)-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351–1358PubMed Okuma T, Matsuoka T, Okamura T et al (2006) 18F-FDG small-animal PET for monitoring the therapeutic effect of computed tomography (CT)-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351–1358PubMed
33.
go back to reference Okuma T, Okamura T, Matsuoka T et al (2006) Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after computed tomography (CT)-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20:115–121PubMedCrossRef Okuma T, Okamura T, Matsuoka T et al (2006) Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after computed tomography (CT)-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20:115–121PubMedCrossRef
34.
go back to reference Avril N (2006) 18F-FDG PET after radiofrequency ablation: Is timing everything? J Nucl Med 47:1235–1237PubMed Avril N (2006) 18F-FDG PET after radiofrequency ablation: Is timing everything? J Nucl Med 47:1235–1237PubMed
35.
go back to reference Hataji O, Yamakado K, Nakatsuka A et al (2005) Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med 44:865–869PubMedCrossRef Hataji O, Yamakado K, Nakatsuka A et al (2005) Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med 44:865–869PubMedCrossRef
36.
go back to reference Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors contributing to cavitation after computed tomography (CT)-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 18:399–404PubMedCrossRef Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors contributing to cavitation after computed tomography (CT)-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 18:399–404PubMedCrossRef
Metadata
Title
Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up
Authors
Jean Palussière
Benjamin Marcet
Edouard Descat
Frédéric Deschamps
Pramod Rao
Alain Ravaud
Véronique Brouste
Thierry de Baère
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 5/2011
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-0048-z

Other articles of this Issue 5/2011

CardioVascular and Interventional Radiology 5/2011 Go to the issue